| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |